PeerView Kidney & Genitourinary Diseases CME/CNE/CPE Audio Podcast-logo

PeerView Kidney & Genitourinary Diseases CME/CNE/CPE Audio Podcast

Education Podcasts >

PeerView is an independent, professional medical publishing company focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerView Publications, PeerView is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.

PeerView is an independent, professional medical publishing company focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerView Publications, PeerView is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
More Information

Location:

United States

Description:

PeerView is an independent, professional medical publishing company focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerView Publications, PeerView is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.

Language:

English


Episodes

Unraveling the Complex Treatment Landscape of Prostate Cancer: Guidance for Delivering Evidence-Based, Patient-Centered Care

10/15/2018
More
Unraveling the Complex Treatment Landscape of Prostate Cancer: Guidance for Delivering Evidence-Based, Patient-Centered Care

Duration:00:44:56

David F. McDermott, MD - Rethinking the Management of Advanced RCC in an Evolving Therapeutic Landscape: Focus on New Options and Patient-Centered Treatment Decisions

7/13/2018
More
Rethinking the Management of Advanced RCC in an Evolving Therapeutic Landscape: Focus on New Options and Patient-Centered Treatment Decisions

Duration:01:17:42

Naiyer Rizvi, MD - Emerging Biomarkers, New Targets, and Rational Combinations: Are We on the Verge of the Next Generation of Immuno-Oncology?

7/11/2018
More
Emerging Biomarkers, New Targets, and Rational Combinations: Are We on the Verge of the Next Generation of Immuno-Oncology?

Duration:01:51:07

Robert Dreicer, MD, MS, MACP, FASCO - Newest Advances and Strategies in Prostate Cancer: Science and Stories on the Evolving Treatment Landscape and Implications for Patient Care

7/9/2018
More
Newest Advances and Strategies in Prostate Cancer: Science and Stories on the Evolving Treatment Landscape and Implications for Patient Care

Duration:01:09:45

Robert Dreicer, MD, MS, MACP, FASCO, MD - Science and Stories: Navigating the Prostate Cancer Landscape: Urologists at the Intersection of Emerging Evidence and Patient Centric Care

7/2/2018
More
Science and Stories: Navigating the Prostate Cancer Landscape: Urologists at the Intersection of Emerging Evidence and Patient Centric Care

Duration:01:03:30

Jonathan E. Rosenberg, MD - Strengthening Our Grip on Immuno-Oncology in Genitourinary Cancers: Understanding Science Through Stories

4/27/2018
More
Strengthening Our Grip on Immuno-Oncology in Genitourinary Cancers: Understanding Science Through Stories

Duration:01:36:26

David F. McDermott, MD - A Master Class on Applying Newer Therapies for Renal Cell Carcinoma: Meeting Real Challenges Through the Advanced Disease Continuum

4/23/2018
More
A Master Class on Applying Newer Therapies for Renal Cell Carcinoma: Meeting Real Challenges Through the Advanced Disease Continuum

Duration:01:14:06

Naiyer Rizvi, MD - Moving in Leaps and Bounds Towards Precision Immuno-Oncology: Latest Biomarker Strategies to Guide Patient Selection and Maximize the Potential of Cancer Immunotherapies

4/4/2018
More
Moving in Leaps and Bounds Towards Precision Immuno-Oncology: Latest Biomarker Strategies to Guide Patient Selection and Maximize the Potential of Cancer Immunotherapies

Duration:01:18:45

Mitchell S. Cairo, MD - Journal Insight on VOD/SOS: Expert Views on New Evidence and Guidelines for Disease Management

3/21/2018
More
Journal Insight on VOD/SOS: Expert Views on New Evidence and Guidelines for Disease Management

Duration:00:39:30

Robin L. Jones, MD - Contemporary Management Strategies in STS: Targeted and Cytotoxic Treatment Options to Optimize Patient Outcomes

12/15/2017
More
Contemporary Management Strategies in STS: Targeted and Cytotoxic Treatment Options to Optimize Patient Outcomes

Duration:01:14:42

Michael Boeckh, MD, PhD - CMV in the Transplant Recipient: At the Crossroads of Current Clinical Challenges and Novel Therapeutic Strategies

11/29/2017
More
CMV in the Transplant Recipient: At the Crossroads of Current Clinical Challenges and Novel Therapeutic Strategies

Duration:01:04:39

David F. McDermott, MD - Defining the Role of Novel Multikinase Inhibitors and Immunotherapies in Advanced RCC: Key Advances and Current Impact on Patient Care

8/2/2017
More
Defining the Role of Novel Multikinase Inhibitors and Immunotherapies in Advanced RCC: Key Advances and Current Impact on Patient Care

Duration:01:05:47

Robert Dreicer, MD, MS, MACP, FASCO - Science and Stories: Making the Most of the Complex Treatment Landscape in Prostate Cancer

7/26/2017
More
Science and Stories: Making the Most of the Complex Treatment Landscape in Prostate Cancer

Duration:01:16:04

Robert Dreicer, MD, MS, MACP, FASCO - Meeting Real Challenges of Bladder Cancer in the Community: How Advances in Immunotherapy Can Impact Patients & Their Care

7/19/2017
More
Meeting Real Challenges of Bladder Cancer in the Community: How Advances in Immunotherapy Can Impact Patients & Their Care

Duration:01:01:06

Robert Dreicer, MD, MS, MACP, FASCO - Urologists at the Intersection of Evidence-Based and Patient-Centric Prostate Cancer Care: Practical Guidance for Everyday Practice

7/10/2017
More
Urologists at the Intersection of Evidence-Based and Patient-Centric Prostate Cancer Care: Practical Guidance for Everyday Practice

Duration:01:06:25

Stanley C. Jordan, MD, FASN - Preventing DSA-Mediated Renal Allograft Injury: Practical Strategies to Maintain Adequate Immunosuppression in Individual Patients

6/16/2017
More
Preventing DSA-Mediated Renal Allograft Injury: Practical Strategies to Maintain Adequate Immunosuppression in Individual Patients

Duration:00:41:33

Naiyer Rizvi, MD - New Concepts in Immunotherapy for Solid Tumors: Novel Immune Approaches, Biomarkers, & Immune-Based Combinations

6/2/2017
More
New Concepts in Immunotherapy for Solid Tumors: Novel Immune Approaches, Biomarkers, & Immune-Based Combinations

Duration:01:57:20

Robert A. Montgomery, MD, D.Phil, FACS - Challenges and Controversies in Transplantation: Test Your Knowledge of New Approaches to Prevent and Treat Antibody-Mediated Rejection

5/24/2017
More
Challenges and Controversies in Transplantation: Test Your Knowledge of New Approaches to Prevent and Treat Antibody-Mediated Rejection

Duration:00:27:50

Robert Dreicer, MD, MS, FACP, FASCO - Need-to-Know Guidance for Navigating the Complex and Expanding Treatment Landscape in Prostate Cancer

5/8/2017
More
Need-to-Know Guidance for Navigating the Complex and Expanding Treatment Landscape in Prostate Cancer

Duration:00:26:24

Phillip D. Levy, MD, MPH, FACEP, FAHA, FACC - Best Practices for Diagnosing and Managing Hyperkalemia: Integrating Evidence-Based Treatment Options and Coordinating Care for Improved Outcomes

4/10/2017
More
Best Practices for Diagnosing and Managing Hyperkalemia: Integrating Evidence-Based Treatment Options and Coordinating Care for Improved Outcomes

Duration:00:29:37